Antibodies used include
anti-Bid (Luo
et al.12 (link)),
anti-Bim (Santa Cruz, Biotechnology, Inc, Dallas, TX, USA, Sc-11425, Calbiochem, San Diego, CA, USA, #202000),
anti-Puma (Santa Cruz, Sc-28226, Pro-Sci, Inc, Poway, CA, USA, 3041),
anti-Bad (Santa Cruz, Sc-8044),
anti-Noxa (Santa Cruz, Sc-56169 Novus Biologicals, Littleton, CO, USA, IMG-349A),
anti-Bax (Santa Cruz, Sc-493),
anti-Bak (Santa Cruz, Sc-832, Cell Signaling Technology, Danvers, MA, USA, #3814),
anti-Bcl-2 (Santa Cruz, Sc-509),
anti-Bcl-xL (Santa Cruz, Sc-8392),
anti-Mcl-1 (Santa Cruz, Sc-819), anti-
β-actin (Sigma-Aldrich, St. Louis, MO, USA, A5441),
anti-PARP (Cell Signaling Technologies, #9524),
anti-GFP (Santa Cruz, Sc-459), and
anti-p53 (Santa Cruz, Sc-393). z-VAD(OMe)-FMK was purchased from MP Biomedicals (Santa Ana, CA, USA).
Thapsigargin was purchased from Adipogen. Corp (San Diego, CA, USA)
ABT-737 was purchased from Cayman Chemical (Ann Arbor, MI, USA). Human recombinant TRAIL was made as previously described.
61 (link)
Zhang J., Huang K., O'Neill K.L., Pang X, & Luo X. (2016). Bax/Bak activation in the absence of Bid, Bim, Puma, and p53. Cell Death & Disease, 7(6), e2266-.